Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 1 hr 44 mins

S&P Futures
3,980.00
+9.75(+0.25%)
Dow Futures
33,886.00
+15.00(+0.04%)
Nasdaq Futures
11,665.75
+49.50(+0.43%)
Russell 2000 Futures
1,839.20
+6.40(+0.35%)
Crude Oil
79.01
+1.77(+2.29%)
Gold
1,768.80
+13.50(+0.77%)

Advertisement

CVS Health Corporation (CVS)

NYSE - NYSE Delayed Price. Currency in USD

Visitors trend2W10W9M

100.41

-0.85

(-0.84%)

At close: 04:00PM EST

100.26

-0.15

(-0.15%)

Pre-Market:

07:31AM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	101.26
Open	100.71
Bid	0.00 x 900
Ask	0.00 x 800
Day's Range	100.07 - 102.10
52 Week Range	86.28 - 111.25
Volume	4,450,024
Avg. Volume	5,986,614

Market Cap	132.547B
Beta (5Y Monthly)	0.71
PE Ratio (TTM)	18.38
EPS (TTM)	5.46
Earnings Date	Feb 07, 2023 - Feb 13, 2023
Forward Dividend & Yield	2.20 (2.37%)
Ex-Dividend Date	Oct 20, 2022
1y Target Est	118.39

All

Investor's Business Daily
CVS Health Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
CVS Health had its Relative Strength (RS) Rating upgraded from 73 to 81 Monday. Decades of market research shows that the best stocks often have an RS Rating of above 80 in the early stages of their moves. CVS Health is trying to complete a consolidation with a 111.35 buy point.
Simply Wall St.
Institutional investors have a lot riding on CVS Health Corporation (NYSE:CVS) with 80% ownership
A look at the shareholders of CVS Health Corporation ( NYSE:CVS ) can tell us which group is most powerful. We can see...
- Dufry AG's (VTX:DUFN) top owners are individual investors with 48% stake, while23% is held by institutions
  Simply Wall St.
- individual investors who own 51% along with institutions invested in Balanced Commercial Property Trust Ltd (LON:BCPT) saw increase in their holdings value last week
  Simply Wall St.
The Wall Street Journal
World’s Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen
As AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be the middlemen negotiating and dispensing the drugs such as Cigna and CVS.

Advertisement

S&P Futures3,980.00+9.75(+0.25%)

Dow Futures33,886.00+15.00(+0.04%)

Nasdaq Futures11,665.75+49.50(+0.43%)

Russell 2000 Futures1,839.20+6.40(+0.35%)

Crude Oil79.01+1.77(+2.29%)

Gold1,768.80+13.50(+0.77%)

CVS Health Corporation (CVS)

Chart Events

Performance Outlook

CVS Health Stock Clears Key Benchmark, Hitting 80-Plus RS Rating

Institutional investors have a lot riding on CVS Health Corporation (NYSE:CVS) with 80% ownership

World’s Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen

S&P Futures
3,980.00
+9.75(+0.25%)

Dow Futures
33,886.00
+15.00(+0.04%)

Nasdaq Futures
11,665.75
+49.50(+0.43%)

Russell 2000 Futures
1,839.20
+6.40(+0.35%)

Crude Oil
79.01
+1.77(+2.29%)

Gold
1,768.80
+13.50(+0.77%)